PRIORITY (Pregnancy CoRonavIrus Outcomes RegIsTrY)
Sponsored by University of California, San Francisco
PRIORITY (Pregnancy CoRonavIrus Outcomes RegIsTrY) is a prospective cohort study of pregnant and recently pregnant women who are: either patients under investigation for COVID-19 or a confirmed case of COVID-19. Data from PRIORITY will be used to evaluate the impact of COVID-19 on the clinical course and pregnancy outcomes of pregnant women and women within 6 weeks of pregnancy.
About COVID-19
Coronavirus disease 2019 (COVID-19) is a respiratory illness that can spread from person to person. The virus that causes COVID-19 is a novel coronavirus that was first identified during an investigation into an outbreak in Wuhan, China.
How is this study designed?
Study Type: Observational [Patient Registry] Estimated Enrollment: 1000 participants Actual Study Start Date: March 20, 2020 Estimated Study Completion Date: March 31, 2024
Who is this study for?
Pregnant women or women who have been pregnant in the last 6 weeks and are under investigation for COVID-19 or who have tested positive for COVID-19.
What should I expect?
- When an eligible patient is referred to the PRIORITY Coordinating Center at UCSF, a UCSF study coordinator will follow-up by phone with the patient and consent verbally.
- The participant will be asked to complete an approval to release medical information.
- The investigators will use patient questionnaires to assess symptoms, maternal clinical course, pregnancy outcomes, and neonatal outcomes from initial investigation of COVID-19 to 6 weeks postpartum or 8 weeks following investigation for non-pregnant women enrolled within 6 weeks of pregnancy.
- The investigators will also obtain all medical records for the participant to data abstract key clinical and pregnancy outcomes.
Have questions or need help?
For general questions about COVID-19 clinical trials, please email [email protected] For study specific inquiries, submit the interest form and you'll be connected to the team.